Barclays’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.25M | Buy |
143,181
+57,969
| +68% | +$2.53M | ﹤0.01% | 1452 |
|
|
2025
Q1 | $2.33M | Sell |
85,212
-15,793
| -16% | -$433K | ﹤0.01% | 1927 |
|
|
2024
Q4 | $4.06M | Buy |
101,005
+9,250
| +10% | +$372K | ﹤0.01% | 1752 |
|
|
2024
Q3 | $4.34M | Buy |
91,755
+42,662
| +87% | +$2.02M | ﹤0.01% | 1628 |
|
|
2024
Q2 | $1.47M | Sell |
49,093
-270,808
| -85% | -$8.09M | ﹤0.01% | 1898 |
|
|
2024
Q1 | $12.9M | Sell |
319,901
-61,880
| -16% | -$2.49M | ﹤0.01% | 901 |
|
|
2023
Q4 | $9.72M | Sell |
381,781
-7,695
| -2% | -$196K | ﹤0.01% | 1080 |
|
|
2023
Q3 | $5.41M | Buy |
389,476
+4,493
| +1% | +$62.5K | ﹤0.01% | 1109 |
|
|
2023
Q2 | $8.85M | Buy |
384,983
+25,055
| +7% | +$576K | 0.01% | 950 |
|
|
2023
Q1 | $10.7M | Sell |
359,928
-30,722
| -8% | -$910K | ﹤0.01% | 783 |
|
|
2022
Q4 | $9.75M | Buy |
390,650
+37,656
| +11% | +$940K | ﹤0.01% | 847 |
|
|
2022
Q3 | $7.69M | Buy |
352,994
+119,857
| +51% | +$2.61M | 0.01% | 910 |
|
|
2022
Q2 | $4.59M | Buy |
233,137
+226,360
| +3,340% | +$4.46M | ﹤0.01% | 1157 |
|
|
2022
Q1 | $287K | Buy |
+6,777
| New | +$287K | ﹤0.01% | 3122 |
|